Erratum: An analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: The experience at a single institution (Surg Today DOI:10.1007/s00595-012-0354-y);An analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: The experience at a single institution

Surgery Today

Volumn 43, Issue 8, 2013, Pages 894-899

  Horiuchi, Kiyomi ^a   Okamoto, Takahiro ^a   Iihara, Masatoshi ^a   Tsukada, Toshihiko ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Genotype phenotype analysis; Multiple endocrine neoplasia type 1; Primary hyperparathyroidism

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; EXON; FAMILY STUDY; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOPHYSIS DISEASE; HYPOPHYSIS TUMOR; MALE; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; OVERALL SURVIVAL; PANCREATIC NEUROENDOCRINE TUMOR; PARATHYROIDECTOMY; PATIENT SELECTION; PHENOTYPE; PRIMARY HYPERPARATHYROIDISM; THYMUS CANCER;

EID: 84880291519     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0644-z     Document Type: Erratum

References (21)

1. Marini F, Falchetti A, Del Monte F, Sala SC, Gozzini A, Luzi E, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Disease. 2006;1:38.
2. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-71.
3. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988;332:85-7.
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404-7.
5. Agarwal SK, Kester MB, Debelenko LV, Hepper C, Emmert-Buck MR, Skarulis MC, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997;6:1169-75.
6. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954;16:363-71.
7. Dean P, van Heerden JA, Farley DR, Thompson GB, Grant CS, Harmsen WS, et al. Are patients with multiple endocrine neoplasia type prone to premature death? World J Surg. 2000;24:1437-41.
8. Erdheim J. Zur normalen und pathologischen Histologie der Glandula thyreoidea, parathyreoidea und Hypophysis. Beitr Pathol Anat. 1903;33:158-236.
9. Underdahl LO, Woolner LB, Black MB. Multiple endocrine adenomas: report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. J Clin Endocrinol Metab. 1953;13:20-47.
10. Hai N, Aoki N, Matuda A, Mori T, Kosugi S. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1. Eur J Endocrinol. 1999;141:475-80.
11. Turner JJO, Leotleta PD, Pannett AAJ, Forbes SA, Bassett JHD, Harding B, et al. Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2002;87:2688-93.
12. Lemos MC, Takker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat. 2008;29:22-32.
13. Morelli A, Falchetti A, Martineti V, Becherini L, Mark M, Friedman E, et al. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol. 2000;142:131-7.
14. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ. Cause of death in multiple endocrine neoplasia type 1. Arch Surg. 1993;128:683-90.
15. Wilson SD, Krzywda EA, Zhu Y, Yen TWF, Wang TS, Sugg SL, et al. The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery. 2008;144:695-702.
16. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and cause of death in MEN1 disease. A GTE (Group d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg. 2010;34:249-55.
17. Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg. 2002;137:641-7.
18. Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab. 2005;90:2603-9.
19. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund N, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery. 2000;128:958-66.
20. Vierimaa O, Ebeling TML, Kytola S, Bloigu R, Eloranta E, Salmi J, et al. Multiple endocrine neoplasia type 1 in northern Finland; clinical features and genotype-phenotype correlation. Eur J Endocrinol. 2007;157:285-94.
21. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Norton JA. Lethality of multiple endocrine neoplasia type 1. World J Surg. 1998;22:581-7.